Skip to Content
US Videos

Grantham, Part 3

This video is part three of five from GMO's Jeremy Grantham's address at the 2018 Morningstar Investment Conference. You can also watch parts one, two, four, and five.

Jeremy Grantham: OK. But now the terrible news. Sorry about this. I tell you, it's hard to live with me, too. Feeding the 11.2 billion, the impact on food sufficiency of population growth and increasing wells, climate change, soil erosion, and many other factors. This is what world population looks like going nowhere forever. When Malthus writes it, it's still below 2 billion. When I get born, it's about 2.3, it has tripled in my lifetime the global population. Whenever you see a chart like that in investing, you know what to do: Go short. The good news that Malthus never dreamt about, our last best hope really is a declining fertility. In the developed countries, we're all below replacement level. The irony here is probably because we've discovered how incredibly expensive and inconvenient children are. This is my scientific reason. There are other reasons, which we'll get to, but they include waiting longer to have children and a side effect of toxicity. Iran is my hero, they used to have seven children, each woman in 1960. And now, they're down to 1.6. My other hero is Bangladesh, dirt-poor then and now, no oil. They also had seven children, and today, they're down to 2.2. It really is amazing. And all they've done is had a persistent program, semi-educated, little bit of training. The women go out into the village and they go out, and they go out, and they go out. And they try very hard, and they have done it. It can be done. 

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.